Yayınlar & Eserler

Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler 8

A Novel Method for Development and Validation of the Degradation Products Analysis of N-Carbamylglutamate with UHPLC by Using Design of Experiment Approach

Arabaci B., YERLİKAYA F., BAŞCI AKDUMAN N. E.
ACS Omega , 2024 (SCI-Expanded) identifier identifier

Development and in vitro evaluation of doxorubicin and celecoxib co-loaded bone targeted nanoparticles

Kozlu S., Sahin A., Ultav G., Yerlikaya F., ÇALIŞ S., ÇAPAN Y.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.45, ss.213-219, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier

Development and validation of a stability-indicating ultra-performance liquid chromatography (UPLC) method for doxycycline hyclate: An optimization of the analytical methodology for a medical countermeasure (MCM) drug

Mohammad A., Yen C. H., Schneider M., Lowry B., YERLİKAYA F., Whitesell G., et al.
Analytical Methods , cilt.10, sa.16, ss.1842-1851, 2018 (SCI-Expanded) identifier

A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles' characteristics and efficacy of intracellular delivery

ŞAHİN A., ESENDAĞLI G., YERLİKAYA F., Caban-Toktas S., Yoyen-Ermis D., HORZUM U., et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY , cilt.45, sa.8, ss.1657-1664, 2017 (SCI-Expanded) identifier identifier identifier

Formulation and process factors influencing product quality and in vitro performance of ophthalmic ointments

Xu X., Al-Ghabeish M., Rahman Z., Krishnaiah Y. S., YERLİKAYA F., Yang Y., et al.
International Journal of Pharmaceutics , cilt.493, sa.1-2, ss.412-425, 2015 (SCI-Expanded) identifier identifier

Development and Evaluation of Paclitaxel Nanoparticles Using a Quality-by-Design Approach

Yerlikaya F., Ozgen A., VURAL İ., Guven O., Karaagaoglu E., Khan M. A., et al.
JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.102, sa.10, ss.3748-3761, 2013 (SCI-Expanded) identifier identifier identifier

The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles

ÖZTÜRK K., Caban S., Kozlu S., Kadayifci E., YERLİKAYA F., ÇAPAN Y.
Pharmazie , cilt.65, sa.9, ss.665-669, 2010 (SCI-Expanded) identifier identifier identifier

LC-UV Determination of Melatonin from Chitosan Nanoparticles

Yerlikaya F., Aktas Y., ÇAPAN Y.
CHROMATOGRAPHIA , cilt.71, ss.967-970, 2010 (SCI-Expanded) identifier identifier
Diğer Dergilerde Yayınlanan Makaleler 9

INCREASING THE SOLUBILITY PROPERTIES OF TETRABENAZINE AT BASIC MEDIUM BY USING SOLID DISPERSION TECHNOLOGY TETRABENAZİNİN BAZİK ORTAMDAKİ ÇÖZÜNME ÖZELLİKLERİNİN KATI DİSPERSİYON TEKNOLOJİSİ İLE ARTIRILMASI

Baş H., YERLİKAYA F., Acartürk F.
Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.49, sa.2, ss.241-263, 2025 (Scopus) identifier

Determination of Caffeine in Human Plasma by Using Liquid Chromatography-Tandem Mass Spectrometry

YERLİKAYA F., SAĞLAM O.
Cumhuriyet Science Journal , cilt.44, sa.3, ss.485-490, 2023 (Hakemli Dergi) Creative Commons License identifier

The Bioequivalence Study of Two Dexketoprofen 25 mg Film-Coated Tablet Formulations in Healthy Males Under Fasting Conditions

YERLİKAYA F., Arslan A., Baş H., Sağlam O., Aytaç S. P.
Turkish Journal of Pharmaceutical Sciences , cilt.20, sa.2, ss.115-120, 2023 (ESCI) Creative Commons License identifier identifier identifier

The Relative Bioavailability Study of Two Cefdinir Formulations in Healthy Males Under Fasting Conditions

YERLİKAYA F., ARSLAN A., Atik O., Kozan S., Parlak A., Özel Karataş M., et al.
FABAD Journal of Pharmaceutical Sciences , cilt.48, sa.1, ss.25-36, 2023 (Scopus) identifier

The Bioequivalence Study of Two Cefdinir 250 mg/5 mL Oral Suspension Formulations in Healthy Males Under Fasting Conditions

YERLİKAYA F., Arslan A., Atik Ö., Kozan S., Parlak A., Özel Karataş M., et al.
Hacettepe University Journal of the Faculty of Pharmacy , cilt.43, sa.1, ss.43-49, 2023 (Scopus) Creative Commons License identifier

APPLICATION OF PLACKETT-BURMAN DESIGN FOR DEVELOPMENT AND EVALUATION OF A BETAMETHASONE SUSPENSION FOR INJECTION FORMULATION BİR BETAMETAZON ENJEKSİYONLUK SÜSPANSİYON FORMÜLASYONUNUN GELİŞTİRİLMESİ VE DEĞERLENDİRİLMESİ İÇİN PLACKETT-BURMAN TASARIMININ UYGULANMASI

YERLİKAYA F., Arslan A., Arabaci B., Gençer P., NEMUTLU E.
Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.47, sa.2, ss.477-489, 2023 (Scopus) identifier identifier

Development of paclitaxel and flurbiprofen co-loaded PLGA nanoparticles: understanding critical formulation and process parameters using Plackett-Burman design

Sahin A., Caban-Toktas S., Tonbul H., Yerlikaya F., AKTAŞ Y., ÇAPAN Y.
ISTANBUL JOURNAL OF PHARMACY , cilt.49, sa.3, ss.161-166, 2019 (ESCI) Sürdürülebilir Kalkınma identifier

A Comparative Evaluation of Polystyrene Divinylbenzene Copolymer HPLC Columns on the Chromatographic Performance of the Compendial Method for Doxycycline Hyclate Capsules: Implications for Method Implementation of a Medical Countermeasure Medication

YERLİKAYA F., Mohammad A., Faustino P., Khan M. A., Saeed K.
Journal of Analytical Sciences, Methods and Instrumentation , cilt.5, sa.3, ss.23-34, 2015 (Hakemli Dergi)

Formulation and In Vitro Evaluation of Paclitaxel Loaded Nanoparticles

Aygul G., YERLİKAYA F., CabanToktas S., Vural I., Capan Y.
Hacettepe University Journal of the Faculty of Pharmacy , cilt.33, sa.1, ss.25-40, 2013 (Scopus) identifier
Metrikler

Yayın

18

Atıf (WoS)

109

H-İndeks (WoS)

5

Atıf (Scopus)

259

H-İndeks (Scopus)

7

Atıf (Diğer Toplam)

6

Proje

10

Fikri Mülkiyet

5

Tez Danışmanlığı

1

Açık Erişim

3
BM Sürdürülebilir Kalkınma Amaçları